Skip to content

Personal Web Page In Clinical Trial Participant Education

Use of a Video-based, Personalized Web Page as a Complement to Standard Patient Education for Clinical Trial Participants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03887091
Enrollment
99
Registered
2019-03-22
Start date
2014-07-21
Completion date
2019-05-31
Last updated
2019-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genitourinary Cancer, Kidney Cancer, Prostate Cancer

Keywords

Web Based Tools, Video Communication, Web-based communication

Brief summary

This research study is evaluating the effectiveness of video and web-based communication in clinical research compared to standard practices.

Detailed description

Research has shown that many clinical trial participants are confused about clinical trials. Common participant misunderstandings include the idea of randomization, benefits to participants' health, the proven nature of the study intervention, and failure to recognize the primary purpose of the trial. There can sometimes be unintended miscommunication between the study doctor and/or nursing staff and participants. Thus, there is a clear need to identify ways to improve communication during clinical trials. The investigator's current culture of web-based information presentation, whether it takes the form of PowerPoint presentations, videos, websites, or audio tools, suggests that adding such technology to the cancer research realm may improve a participant's clinical trial experience and possibly improve participant understanding and safety while enrolled on a clinical trial. Video and web-based tools in cancer research have the potential to transform clinical trial practice.

Interventions

OTHERPostwire

Postwire© is a web-based, video platform

Sponsors

Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants must be ≥ 18 years of age * Participants must have an advanced or metastatic genitourinary malignancy (prostate or kidney cancer) * Participants must be consented to one of the selected clinical trials (see Appendix A) * Participants must be able to read and write English * Participants must have access to the internet at a minimum of once per week * Participants must use the internet at a minimum of once per week * Participants must feel at least somewhat confident in how to use the internet, as determined by the eligibility questionnaire to be completed by the participant

Design outcomes

Primary

MeasureTime frameDescription
Number of cumulative participant caused violations over 4 cycles168 DaysWilcoxon Rank Sum Test (one-sided alpha = 0.10).

Secondary

MeasureTime frameDescription
Number of times participants accessed the webpage168 DaysPearson correlation coefficient (or Spearman, if appropriate
number of participant-caused protocol violations42 DaysPearson correlation coefficient (or Spearman, if appropriate)
Participant reported outcomes (PRO) center on treatment satisfactionPROs collected on Cycle 1 Day 1 and each day 1 of a cycle thereafter until Cycle 7 Day 1, approximately over the course of 7 months.FACIT-TS-PS
Participant reported outcomes (PRO) on Perceived StressPROs collected on Cycle 1 Day 1 and each day 1 of a cycle thereafter until Cycle 7 Day 1, approximately over the course of 7 months.PSS-10

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026